Abstracts from the 6th AFMC International Medicinal Chemistry Symposium: July 8 - 11, 2007, Istanbul, Turkey
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Barcelona [u.a.]
Prous
2007
|
| Schriftenreihe: | Drugs of the future
32 : Suppl. A |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-H. |
| Beschreibung: | 155 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV022615095 | ||
| 003 | DE-604 | ||
| 005 | 20080121 | ||
| 007 | t | ||
| 008 | 070820s2007 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)255847893 | ||
| 035 | |a (DE-599)BVBBV022615095 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 084 | |a 15,3 |2 ssgn | ||
| 111 | 2 | |a International Medicinal Chemistry Symposium |n 6 |d 2007 |c Istanbul |j Verfasser |0 (DE-588)3067366-5 |4 aut | |
| 245 | 1 | 0 | |a Abstracts from the 6th AFMC International Medicinal Chemistry Symposium |b July 8 - 11, 2007, Istanbul, Turkey |
| 246 | 1 | 3 | |a Sixth AFMC International Medicinal Chemistry Symposium |
| 264 | 1 | |a Barcelona [u.a.] |b Prous |c 2007 | |
| 300 | |a 155 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Drugs of the future |v 32 : Suppl. |v A | |
| 500 | |a Einzelaufnahme eines Zeitschr.-H. | ||
| 650 | 0 | 7 | |a Pharmazeutische Chemie |0 (DE-588)4132158-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2007 |z Istanbul |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Chemie |0 (DE-588)4132158-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 710 | 2 | |a Asian Federation for Medicinal Chemistry |e Sonstige |0 (DE-588)5262303-8 |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015821252&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015821252 | ||
Datensatz im Suchindex
| _version_ | 1804136772538466304 |
|---|---|
| adam_text | DRUGS * FUTURE VOLUME 32, SUPPL. A, JULY 2007 ABSTRACTS FROM THE 6 TH
AFMC INTERNATIONAL ^MEDICINAL CHEMISTRY SYMPOSIUM - ; JULY 8-11, 2007,
ISTANBUL, TURKEY P R O U S S C I E N C E B A E C F I O F. A P M I L A
D F L P H I A DRUGS FUTURE VOLUME 32, SUPPL. A, JULY 2007 6TH AFMC
INTERNATIONAL MEDICINAL CHEMISTRY SYMPOSIUM OPENING LECTURE OL
STRATEGY-LIFE CYCLE MANAGEMENT OF DRUGS TOSHI-HIKO KOBAYASHI 1 PLENARY
LECTURES PL-1 SYNTHESIS OF PHARMACEUTICALS THROUGH ASYMMETRIC TWO-CENTER
CATALYSIS MASAKATSU SHIBASAKI 1 PL-2 STRUCTURAL INSIGHTS INTO
LIGAND-LNDUCED ACTIVATION OF THE INSULIN RECEPTOR COLIN WARD 1 PL-3
CHEMOINFORMATICS IN DRUG DESIGN JOHANN GASTEIGER 2 INVITED LECTURES IL-1
SYNTHESIS, SAR, AND PRECLINICAL EVALUATION OF MARINE NATURAL PRODUCTS
THAT MODULATE PI3 KINASE SIGNALING RAYMOND J. ANDERSEN 2 IL-2
PROTEIN-PROTEIN INTERACTIONS PATRICK CHENE 3 IL-3 PREDICTIVE QSAR
MODELING WORKFLOW AND ITS APPLICATION TO SUPPORT THE EXPERIMENTAL
DISCOVERY OF BIOLOGICALLY ACTIVE COMPOUNDS ALEXTROPSHA 3 IL-4 CANCER
PREVENTIVE FOOD PHYTOCHEMICALS: SCREENING, ANIMAL MODEL STUDIES AND
POSSIBLE ACTION MECHANISMS HAJIME OHIGASHI 3 IL-5 HOW TO ENSURE SAFETY
OF DRUGS-EFFORTS BY JAPAN S MINISTRY OF HEALTH, LABOUR, AND WELFARE
(MHLW) HISAYOSHI MORIOKA 4 IL-6 DEVELOPMENT OF NOVEL CLINICAL CANDIDATES
TARGETING A 3 ADENOSINE RECEPTOR LAK SHIN JEONG 4 IL-7 ACROLEIN AS A
NOVEL BIOCHEMICAL MARKER FOR CEREBRAL STROKE AND SILENT BRAIN INFARCTION
KAZUEI IGARASHI 5 IL-8 NEW METHODS IN DRUG DISCOVERY VICTOR KARTSEV 5
IL-9 BACTERIAL MEMBRANE DRUG EFFLUX AND RECEPTOR PROTEINS PETER
HENDERSON 6 IL-10 CXCR4 ANTAGONISTS; RELEVANCE TO CANCER CHEMOTHERAPY
NOBUTAKA FUJII 6 IL-11 STRUCTURAL AND MECHANISTIC STUDIES ON CYTOCHROMES
P450 FRANK E. BLANEY 7 IL-12 DEVELOPMENT OF ANTICANCER DRUG, BELOTECAN
SOONKHAHN 7 ORAL PRESENTATIONS OP-1 COMBINATORIAL BIOSYNTHESIS: A NEW
TOOL FOR DEVELOPING STRUCTURAL DIVERSITY IN NATURAL PRODUCTS JOSE A.
SALAS 11 OP-2 COMBINATORIAL BIOSYNTHESIS AND STUDIES ON BIOSYNTHETIC KEY
ENZYMES - PERSPECTIVES FOR DRUG DISCOVERY JURGEN ROHR 11 OP-3 TOWARDS
BEST-IN-CLASS HSP90 INHIBITORS: A SYNTHETIC BIOLOGY APPROACH
MING-QIANG ZHANG 11 OP-4 DIRECTED BIOSYNTHESIS AND SAR OF
MANNOPEPTIMYCINS FRANK E. KOEHN 12 OP-5 STRUCTURAL ELUCIDATION OF
CYCLODEXTRIN INCLUSION COMPLEXES OF NOVEL ALLICIN-MIMICS MINOCAIRA 12
OP-6 ASSESSING THE DRUG ABILITY OF PROTEIN-PROTEIN INTERACTIONS
XAVIERBARRIL 12 OP-7 ASSOCIATION OF PROTEIN BINDINGS SITES WITH
FLUCTUATION BEHAVIOR OF RESIDUES TURKAN HALILOGLU 13 OP-8 FRAGMENT-BASED
APPROACHES TO INHIBITOR DISCOVERY: TARGETING COFACTOR-BINDING SITES AND
PROTEIN-PROTEIN INTERACTIONS ALESSIO CIULLI 13 OP-9 NMR STUDY ON
MEMBRANE PROTEINS-LIGANDS INTERACTIONS ICHIOSHIMADA 14 OP-10 INSIGHT
INTO THE FOLDING INHIBITION OF HIV-1 PROTEASE BY A SMALL PEPTIDE
MASSIMILIANO BONOMI 14 OP-11 MOLECULAR MODELLING AS A TOOL FOR THE
DESIGN OF DRUG CANDIDATES MAURIZIO BOTTA 15 OP-12 MODELING STRATEGIES
USED TO SUPPORT THE DISCOVERY OF CASPASE-3 INHIBITORS GREGORYJ. TAWA 15
OP-13 MOLECULAR MODELLING STUDIES ON SOME EUKARYOTIC TOPOISOMERASE II
ENZYME INHIBITOR FUSED HETEROCYCLIC COMPOUNDS ILKAYYILDIZ. 15 OP-14 A
FAST EMPIRICAL SCORING METHOD FOR DOCKING AND VIRTUAL SCREENING PIETRO
COZZINI 16 OP-15 A COMPARATIVE MOLECULAR FIELD ANALYSIS (COMFA) STUDY OF
FLAVONOIDS ACTIVE AGAINST HT-29 COLON CARCINOMA BO CHENG WANG 16 OP-16
MODELLING LIGAND SELECTIVITY: AN INTEGRATED APPROACH VLADIMIR A. PALYUUN
17 OP-17 ANTI-DEMENTIA COMPOUNDS FROM THE MUSHROOM HERICIUM ERINACEUM
HIROKAZU KAWAGISHI 17 OP-18 PHAGOCYTOSI S OF POLYMER MICROSPHERES BY
ALVEOLAR MACROPHAGES FOR OVERCOMING TUBERCULOSIS HIROSHI TERADA 18 OP-19
SMALL MOLECULE POTASSIUM-CHANNEL BLOCKERS AS POTENTIAL TREATMENTS FOR
AUTOIMMUNE DISEASE JONATHAN B. BAELL 18 OP-20 RECENT PROGRESS IN
BIOSYNTHETIC STUDIES ON BIOACTIVE TRITERPENOID SAPONINS YUTAKA EBIZUKA
19 OP-21 COMPOSITION AND ANTIOXIDANT ACTIVITIES OF POLYSACCHARIDES FROM
MYCELIAL CULTURE OF A MEDICINAL FUNGUS CORDYCEPS SINENSIS CS-HK1
JIAN-YONGWU 19 OP-22 INTERSECTION OF REGULATORY REQUIREMENTS AND
INTELLECTUAL PROPERTY RIGHTS MARKPAXTON 20 OP-23 REGULATORY DELAYS AND
PATENT TERMS MICHAEL J. CAINE 20 OP-24 INTELLECTUAL PROPERTY RIGHTS IN
THE PHARMACEUTICAL INDUSTRY: TURKISH EXPERIENCE HULYACAYLL 21 OP-25
TRIAZOLE ANALOGUE OF THE IMMUNOSTIMULANT A-GALACTOSYLCERAMIDE (KRN7000):
SYNTHESIS AND EVALUATION SANGHEEKIM 21 OP-26 SMALL-MOLECULE INHIBITION
OF SIDEROPHORE BIOSYNTHESIS IN MYCOBACTERIUM TUBERCULOSIS AND YERSINIA
PESTIS JAE-SANGRYU 21 OP-27 UDENAFIL, A NEW LONG ACTING PDE5 INHIBITOR
MOOHIYOO 22 OP-28 MOLECULAR DYNAMICS SIMULATIONS OF HIV-1 PROTEASE
MONOMER: ASSEMBLY OF N-TERMINUS AND C-TERMINUS INTO P- SHEET IN WATER
SOLUTION MAO-SHENG CHENG 22 OP-29 THERAPEUTIC POTENTIAL OF THE POTENT BK
CA CHANNEL OPENERS: SYNTHESIS, SAR, MECHANISM OF ACTION AND
PHARMACOLOGICAL EVALUATION OF BENZOFUROINDOLE ANALOGUES YONG-CHULKIM 22
OP-30 DEVELOPMENT OF BIOIMAGING FLUORESCENT PROBES BASED ON
PHOTO-INDUCED ELECTRON TRANSFER TETSUO NAGANO 2 3 OP-31 EFFICIENT
FLUORESCENCE ASSAY FOR SERINE/THREONINE KINASES NAOKI UMEZAWA 23 OP-32
HYDROGEN PEROXIDE REGULATES SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS NORIO
MATSUKI 2 4 OP-33 HIGH-THROUGHPUT REPURPOSING AND ITS APPLICATION TO THE
STUDY OF ANGIOTENSIN AT, ANTAGONISTS DAVID ARAGONES 2 4 OP-34
DEVELOPMENT OF BENZOFURAZAN LABELING REAGENTS FOR LC/MS/MS AND THEIR
APPLICATION TO BIOMARKER ANALYSIS TOMOFUMI SANTA 25 OP-35 ACQUISITION OF
SELECTIVE SRC KINASE INHIBITOR VIA A GLOBAL TARGETING STRATEGY JUNG-MI
HAH 25 OP-36 NOVEL SPARSE BAYESIAN FEATURE SELECTION METHODS FOR
MICROARRAY ANALYSIS AND QSAR VARIABLE SELECTION DAVID WINKLER 26 OP-37
DG-051: A NOVEL LEUKOTRIENE A4 HYDROLASE INHIBITOR FOR THE TREATMENT OF
MYOCARDIAL INFARCTION AND STROKE JASBIR SINGH 26 OP-38 TD-DFT STUDY OF
DIFFERENT GENERATION OF PHOTOSENSITIZERS ACTIVE IN THE PHOTODYNAMIC
THERAPY NINORUSSO 26 OP-39 DEVELOPMENT OF POTENT INHIBITORS OF A
CRITICAL MEDIATOR OF AUTOIMMUNE AND INFLAMMATORY DISEASES YOUSEF AL-ABED
27 OP-40 A NOVEL TECHNIQUES FOR VIRTUAL DISCOVERY FOR STUDY OF
MULTISTAGE BIOPROCESSES VLADIMIR POTEMKIN 27 OP-41 ANTINEOPLASTIC
ACTIVITY OF HETEROCYCLIC COMPOUNDS IN MULTI-DRUG RESISTANT CANCER CELLS
HERMANN LAGE 27 OP-42 DESIGN OF INHIBITORS OF THE HUMAN IMMUNODEFICIENCY
VIRUS (HIV) INTEGRASE ENZYME RENATE GRIFFITH 28 OP-43 HOW MANY CHANCES A
MICROORGANISM HAS, TO GET RESISTANT TO AN ANTIMICROBIAL DRUG?
TANILKOCAGOZ 28 OP-44 DRUG DISCOVERY FOR SARS AND OTHER HUMAN CORONA
VIRUSES TARGETING 3C PROTEASES PO-HUANG LIANG 29 OP-45 STRUCTURE
ACTIVITY RELATIONSHIP OF SOME NEW SECONDARY METABOLITES, AMPHIDINOLS,
ISOLATED FROM MARINE DINOFLAGELLATE, WITH MODE OF ACTION STUDIES
NAGYMORSY. 29 OP-46 ENANTIOSELECTIVE SYNTHESIS OF ALPHA-HYDROXY ACIDS
WITH BIOLOGICAL INTERESTS BIING-JIUN UANG 30 OP-47 THE RESEARCH AND
DEVELOPMENT OF THE NOVEL ANTIPSYCHOTIC ARIPIPRAZOLE TETSURO KIKUCHI 30
OP-48 DEVELOPMENT OF INHIBITORS OF INDOLEAMINE 2,3-DIOXIGENASE (IDO)
YUUSAKU YOKOYAMA 30 OP-49 SYNTHESIS OF PHARMACEUTICALLY USEFUL UNNATURAL
AMINO ACIDS UTILIZING BIOTRANSFORMATION AS A KEY STEP KUNISUKE IZAWA 31
OP-50 DEVELOPMENT OF 4(5)-(6-ALKYLPYRIDIN-2-YL)IMIDAZOLES AS
TRANSFORMING GROWTH FACTOR-B TYPEI RECEPTOR KINASE INHIBITORS AS
ANTI-FIBROTIC AGENTS DAE-KEE KIM 31 OP-51 A NOVEL APPROACH TO THE
DISCOVERY OF SAFER ANTI-INFLAMMATORY STEROIDS: ANTEDRUGS HENRY J. LEE 32
OP-52 MAGIC NANO BIOMATERIALS AS PHOTO-INDUCED DNA-CLEAVING AGENTS
JIHRUHWU 32 OP-53 PUTATIVE BIOACTIVE CONFORMERS OF SMALL MOLECULES: A
CONCERTED APPROACH USING NMR SPECTROSCOPY AND COMPUTATIONAL CHEMISTRY
THOMAS MAVROMOUSTAKOS 33 OP-54 DEVELOPMENT OF A ROBUST WORK-UP PROCESS
FOR SOLUTION-PHASE HIGH THROUGHPUT LIBRARY SYNTHESIS TO ADDRESS
ENVIRONMENTAL AND SAMPLE TRACKING ISSUES NORITAKA KURODA 33 OP-55
MODELLING DRUG AND TOXIN BINDING TO ION CHANNELS SERDAR KUYUCAK 33 OP-56
SYNTHETIC STUDIES OF NON-EPIMERIZABLE ISOSTERIC ANALOGS FOR THE PUTATIVE
METABOLITES OF THALIDOMIDE TOMOYUKI SAITO 34 OP-57 FROM BENCH TO DRUG
CANDIDATE: DESIGN AND SYNTHESIS OF 5,6-FUSED-HETEROAROMATICS AS
ANTICANCER AGENTS HSING-PANG HSIEH 34 OP-58 DISCOVERY OF ANTI-CANCER
DRUG CANDIDATES ON THE BASIS OF STRUCTURAL CHEMOPROTEOMICS SEONGGU RO 35
OP-59 A NOVEL ORAL INDOLINE-SULFONAMIDE DERIVATIVE, J30, EXHIBITS POTENT
ACTIVITY AGAINST HUMAN CANCER CELLS BOTH IN VITRO AND IN VIVO THROUGH
DISRUPTION OF MICROTUBULE JANG-YANG CHANG 35 OP-60 SYNTHESIS AND
EVALUATION OF SUBSTITUTED PYRROLO[2,3-A(]PYRIMIDINES AS ANTITUMOR
ANTIMITOTICS THAT ALSO REVERSE TUMOR RESISTANCE ALEEM GANGJEE 36 OP-61
AZOLE-BRIDGED DIPLATINUM ANTICANCER DRUGS: ESCAPING REPAIR MECHANISM AND
AVOIDING CROSS-RESISTANCE BY MODULATING DNA-FLEXIBILITY ALESSANDRA
MAGISTRATO 36 OP-62 STRUCTURAL INVESTIGATION, IN VITRO ANTITUMOR PROFILE
AND AROMATASE INHIBITION EFFECTS OF NEW TRIORGANOTIN ANALOGUES OF
4-OH-ANDROSTENEDIONE (FORMESTANE) VASILIKI VALLA 37 POSTER
PRESENTATIONS (GROUP A) CHEMISTRY AND BIOLOGY FOR PHARMACEUTICALS (PA-1
TO PA-43) 38 NATURAL PRODUCTS BIOLOGICAL/PHYSIOLOGICAL ACTIVITIES (PA-44
TO PA-64) 57 BIOSYNTHETIC MEDICINAL CHEMISTRY (PA-65 TO PA-78) 66 NOVEL
DRUG TARGETS AS A BASIS OF NEW DRUG DEVELOPMENT (PA-79 TO PA-89) 72
POSTER PRESENTATIONS (GROUP B) PREDICTIVE IN SILICO METHODS AND QSAR
(PB-1 TO PB-22) 78 NEW METHODS FOR DRUG DISCOVERY (PB-23 TO PB-49) 87
RECENT APPROACHES IN ANTICANCER THERAPY (PB-50 TO PB-71) 101 ADME/TOX
(PB-72 TO PB-83) 110 POSTER PRESENTATIONS (GROUP C) MULTI-DRUG
RESISTANCE AND ITS REVERSAL (PC-1 TO PC-32) 116 OTHERS (PC-33 TO PC-73)
129 AUTHOR INDEX 147 THIS ABSTRACT BOOK HAS BEEN PRODUCED USING
ELECTRONIC SUBMISSIONS. EVERY EFFORT HAS BEEN MADE TO REPRODUCE THE
ABSTRACTS AS SUBMITTED AND AS RECEIVED BY THE PUBLISHER. A SELECTED
NUMBER OF PRESENTATIONS WILL BE AVAILABLE AS WEBCASTS. VISIT
HTTP://WWW.PROUS.COM/AIMECS07 FOR DETAILS
|
| adam_txt |
DRUGS ""*"FUTURE VOLUME 32, SUPPL. A, JULY 2007 ABSTRACTS FROM THE 6 TH
AFMC INTERNATIONAL ^MEDICINAL CHEMISTRY SYMPOSIUM - ; JULY 8-11, 2007,
ISTANBUL, TURKEY P R O U S S C I E N C E B A E C F I O F. A P M I L A
D F L P H I A DRUGS FUTURE VOLUME 32, SUPPL. A, JULY 2007 6TH AFMC
INTERNATIONAL MEDICINAL CHEMISTRY SYMPOSIUM OPENING LECTURE OL
STRATEGY-LIFE CYCLE MANAGEMENT OF DRUGS TOSHI-HIKO KOBAYASHI 1 PLENARY
LECTURES PL-1 SYNTHESIS OF PHARMACEUTICALS THROUGH ASYMMETRIC TWO-CENTER
CATALYSIS MASAKATSU SHIBASAKI 1 PL-2 STRUCTURAL INSIGHTS INTO
LIGAND-LNDUCED ACTIVATION OF THE INSULIN RECEPTOR COLIN WARD 1 PL-3
CHEMOINFORMATICS IN DRUG DESIGN JOHANN GASTEIGER 2 INVITED LECTURES IL-1
SYNTHESIS, SAR, AND PRECLINICAL EVALUATION OF MARINE NATURAL PRODUCTS
THAT MODULATE PI3 KINASE SIGNALING RAYMOND J. ANDERSEN 2 IL-2
PROTEIN-PROTEIN INTERACTIONS PATRICK CHENE 3 IL-3 PREDICTIVE QSAR
MODELING WORKFLOW AND ITS APPLICATION TO SUPPORT THE EXPERIMENTAL
DISCOVERY OF BIOLOGICALLY ACTIVE COMPOUNDS ALEXTROPSHA 3 IL-4 CANCER
PREVENTIVE FOOD PHYTOCHEMICALS: SCREENING, ANIMAL MODEL STUDIES AND
POSSIBLE ACTION MECHANISMS HAJIME OHIGASHI 3 IL-5 HOW TO ENSURE SAFETY
OF DRUGS-EFFORTS BY JAPAN'S MINISTRY OF HEALTH, LABOUR, AND WELFARE
(MHLW) HISAYOSHI MORIOKA 4 IL-6 DEVELOPMENT OF NOVEL CLINICAL CANDIDATES
TARGETING A 3 ADENOSINE RECEPTOR LAK SHIN JEONG 4 IL-7 ACROLEIN AS A
NOVEL BIOCHEMICAL MARKER FOR CEREBRAL STROKE AND SILENT BRAIN INFARCTION
KAZUEI IGARASHI 5 IL-8 NEW METHODS IN DRUG DISCOVERY VICTOR KARTSEV 5
IL-9 BACTERIAL MEMBRANE DRUG EFFLUX AND RECEPTOR PROTEINS PETER
HENDERSON 6 IL-10 CXCR4 ANTAGONISTS; RELEVANCE TO CANCER CHEMOTHERAPY
NOBUTAKA FUJII 6 IL-11 STRUCTURAL AND MECHANISTIC STUDIES ON CYTOCHROMES
P450 FRANK E. BLANEY 7 IL-12 DEVELOPMENT OF ANTICANCER DRUG, BELOTECAN
SOONKHAHN 7 ORAL PRESENTATIONS OP-1 COMBINATORIAL BIOSYNTHESIS: A NEW
TOOL FOR DEVELOPING STRUCTURAL DIVERSITY IN NATURAL PRODUCTS JOSE A.
SALAS 11 OP-2 COMBINATORIAL BIOSYNTHESIS AND STUDIES ON BIOSYNTHETIC KEY
ENZYMES - PERSPECTIVES FOR DRUG DISCOVERY JURGEN ROHR 11 OP-3 TOWARDS
'BEST-IN-CLASS' HSP90 INHIBITORS: A SYNTHETIC BIOLOGY APPROACH
MING-QIANG ZHANG 11 OP-4 DIRECTED BIOSYNTHESIS AND SAR OF
MANNOPEPTIMYCINS FRANK E. KOEHN 12 OP-5 STRUCTURAL ELUCIDATION OF
CYCLODEXTRIN INCLUSION COMPLEXES OF NOVEL ALLICIN-MIMICS MINOCAIRA 12
OP-6 ASSESSING THE DRUG ABILITY OF PROTEIN-PROTEIN INTERACTIONS
XAVIERBARRIL 12 OP-7 ASSOCIATION OF PROTEIN BINDINGS SITES WITH
FLUCTUATION BEHAVIOR OF RESIDUES TURKAN HALILOGLU 13 OP-8 FRAGMENT-BASED
APPROACHES TO INHIBITOR DISCOVERY: TARGETING COFACTOR-BINDING SITES AND
PROTEIN-PROTEIN INTERACTIONS ALESSIO CIULLI 13 OP-9 NMR STUDY ON
MEMBRANE PROTEINS-LIGANDS INTERACTIONS ICHIOSHIMADA 14 OP-10 INSIGHT
INTO THE FOLDING INHIBITION OF HIV-1 PROTEASE BY A SMALL PEPTIDE
MASSIMILIANO BONOMI 14 OP-11 MOLECULAR MODELLING AS A TOOL FOR THE
DESIGN OF DRUG CANDIDATES MAURIZIO BOTTA 15 OP-12 MODELING STRATEGIES
USED TO SUPPORT THE DISCOVERY OF CASPASE-3 INHIBITORS GREGORYJ. TAWA 15
OP-13 MOLECULAR MODELLING STUDIES ON SOME EUKARYOTIC TOPOISOMERASE II
ENZYME INHIBITOR FUSED HETEROCYCLIC COMPOUNDS ILKAYYILDIZ. 15 OP-14 A
FAST EMPIRICAL SCORING METHOD FOR DOCKING AND VIRTUAL SCREENING PIETRO
COZZINI 16 OP-15 A COMPARATIVE MOLECULAR FIELD ANALYSIS (COMFA) STUDY OF
FLAVONOIDS ACTIVE AGAINST HT-29 COLON CARCINOMA BO CHENG WANG 16 OP-16
MODELLING LIGAND SELECTIVITY: AN INTEGRATED APPROACH VLADIMIR A. PALYUUN
17 OP-17 ANTI-DEMENTIA COMPOUNDS FROM THE MUSHROOM HERICIUM ERINACEUM
HIROKAZU KAWAGISHI 17 OP-18 PHAGOCYTOSI S OF POLYMER MICROSPHERES BY
ALVEOLAR MACROPHAGES FOR OVERCOMING TUBERCULOSIS HIROSHI TERADA 18 OP-19
SMALL MOLECULE POTASSIUM-CHANNEL BLOCKERS AS POTENTIAL TREATMENTS FOR
AUTOIMMUNE DISEASE JONATHAN B. BAELL 18 OP-20 RECENT PROGRESS IN
BIOSYNTHETIC STUDIES ON BIOACTIVE TRITERPENOID SAPONINS YUTAKA EBIZUKA
19 OP-21 COMPOSITION AND ANTIOXIDANT ACTIVITIES OF POLYSACCHARIDES FROM
MYCELIAL CULTURE OF A MEDICINAL FUNGUS CORDYCEPS SINENSIS CS-HK1
JIAN-YONGWU 19 OP-22 INTERSECTION OF REGULATORY REQUIREMENTS AND
INTELLECTUAL PROPERTY RIGHTS MARKPAXTON 20 OP-23 REGULATORY DELAYS AND
PATENT TERMS MICHAEL J. CAINE 20 OP-24 INTELLECTUAL PROPERTY RIGHTS IN
THE PHARMACEUTICAL INDUSTRY: TURKISH EXPERIENCE HULYACAYLL 21 OP-25
TRIAZOLE ANALOGUE OF THE IMMUNOSTIMULANT A-GALACTOSYLCERAMIDE (KRN7000):
SYNTHESIS AND EVALUATION SANGHEEKIM 21 OP-26 SMALL-MOLECULE INHIBITION
OF SIDEROPHORE BIOSYNTHESIS IN MYCOBACTERIUM TUBERCULOSIS AND YERSINIA
PESTIS JAE-SANGRYU 21 OP-27 UDENAFIL, A NEW LONG ACTING PDE5 INHIBITOR
MOOHIYOO 22 OP-28 MOLECULAR DYNAMICS SIMULATIONS OF HIV-1 PROTEASE
MONOMER: ASSEMBLY OF N-TERMINUS AND C-TERMINUS INTO P- SHEET IN WATER
SOLUTION MAO-SHENG CHENG 22 OP-29 THERAPEUTIC POTENTIAL OF THE POTENT BK
CA CHANNEL OPENERS: SYNTHESIS, SAR, MECHANISM OF ACTION AND
PHARMACOLOGICAL EVALUATION OF BENZOFUROINDOLE ANALOGUES YONG-CHULKIM 22
OP-30 DEVELOPMENT OF BIOIMAGING FLUORESCENT PROBES BASED ON
PHOTO-INDUCED ELECTRON TRANSFER TETSUO NAGANO 2 3 OP-31 EFFICIENT
FLUORESCENCE ASSAY FOR SERINE/THREONINE KINASES NAOKI UMEZAWA 23 OP-32
HYDROGEN PEROXIDE REGULATES SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS NORIO
MATSUKI 2 4 OP-33 HIGH-THROUGHPUT REPURPOSING AND ITS APPLICATION TO THE
STUDY OF ANGIOTENSIN AT, ANTAGONISTS DAVID ARAGONES 2 4 OP-34
DEVELOPMENT OF BENZOFURAZAN LABELING REAGENTS FOR LC/MS/MS AND THEIR
APPLICATION TO BIOMARKER ANALYSIS TOMOFUMI SANTA 25 OP-35 ACQUISITION OF
SELECTIVE SRC KINASE INHIBITOR VIA A GLOBAL TARGETING STRATEGY JUNG-MI
HAH 25 OP-36 NOVEL SPARSE BAYESIAN FEATURE SELECTION METHODS FOR
MICROARRAY ANALYSIS AND QSAR VARIABLE SELECTION DAVID WINKLER 26 OP-37
DG-051: A NOVEL LEUKOTRIENE A4 HYDROLASE INHIBITOR FOR THE TREATMENT OF
MYOCARDIAL INFARCTION AND STROKE JASBIR SINGH 26 OP-38 TD-DFT STUDY OF
DIFFERENT GENERATION OF PHOTOSENSITIZERS ACTIVE IN THE PHOTODYNAMIC
THERAPY NINORUSSO 26 OP-39 DEVELOPMENT OF POTENT INHIBITORS OF A
CRITICAL MEDIATOR OF AUTOIMMUNE AND INFLAMMATORY DISEASES YOUSEF AL-ABED
27 OP-40 A NOVEL TECHNIQUES FOR VIRTUAL DISCOVERY FOR STUDY OF
MULTISTAGE BIOPROCESSES VLADIMIR POTEMKIN 27 OP-41 ANTINEOPLASTIC
ACTIVITY OF HETEROCYCLIC COMPOUNDS IN MULTI-DRUG RESISTANT CANCER CELLS
HERMANN LAGE 27 OP-42 DESIGN OF INHIBITORS OF THE HUMAN IMMUNODEFICIENCY
VIRUS (HIV) INTEGRASE ENZYME RENATE GRIFFITH 28 OP-43 HOW MANY CHANCES A
MICROORGANISM HAS, TO GET RESISTANT TO AN ANTIMICROBIAL DRUG?
TANILKOCAGOZ 28 OP-44 DRUG DISCOVERY FOR SARS AND OTHER HUMAN CORONA
VIRUSES TARGETING 3C PROTEASES PO-HUANG LIANG 29 OP-45 STRUCTURE
ACTIVITY RELATIONSHIP OF SOME NEW SECONDARY METABOLITES, AMPHIDINOLS,
ISOLATED FROM MARINE DINOFLAGELLATE, WITH MODE OF ACTION STUDIES
NAGYMORSY. 29 OP-46 ENANTIOSELECTIVE SYNTHESIS OF ALPHA-HYDROXY ACIDS
WITH BIOLOGICAL INTERESTS BIING-JIUN UANG 30 OP-47 THE RESEARCH AND
DEVELOPMENT OF THE NOVEL ANTIPSYCHOTIC ARIPIPRAZOLE TETSURO KIKUCHI 30
OP-48 DEVELOPMENT OF INHIBITORS OF INDOLEAMINE 2,3-DIOXIGENASE (IDO)
YUUSAKU YOKOYAMA 30 OP-49 SYNTHESIS OF PHARMACEUTICALLY USEFUL UNNATURAL
AMINO ACIDS UTILIZING BIOTRANSFORMATION AS A KEY STEP KUNISUKE IZAWA 31
OP-50 DEVELOPMENT OF 4(5)-(6-ALKYLPYRIDIN-2-YL)IMIDAZOLES AS
TRANSFORMING GROWTH FACTOR-B TYPEI RECEPTOR KINASE INHIBITORS AS
ANTI-FIBROTIC AGENTS DAE-KEE KIM 31 OP-51 A NOVEL APPROACH TO THE
DISCOVERY OF SAFER ANTI-INFLAMMATORY STEROIDS: ANTEDRUGS HENRY J. LEE 32
OP-52 MAGIC NANO BIOMATERIALS AS PHOTO-INDUCED DNA-CLEAVING AGENTS
JIHRUHWU 32 OP-53 PUTATIVE BIOACTIVE CONFORMERS OF SMALL MOLECULES: A
CONCERTED APPROACH USING NMR SPECTROSCOPY AND COMPUTATIONAL CHEMISTRY
THOMAS MAVROMOUSTAKOS 33 OP-54 DEVELOPMENT OF A ROBUST WORK-UP PROCESS
FOR SOLUTION-PHASE HIGH THROUGHPUT LIBRARY SYNTHESIS TO ADDRESS
ENVIRONMENTAL AND SAMPLE TRACKING ISSUES NORITAKA KURODA 33 OP-55
MODELLING DRUG AND TOXIN BINDING TO ION CHANNELS SERDAR KUYUCAK 33 OP-56
SYNTHETIC STUDIES OF NON-EPIMERIZABLE ISOSTERIC ANALOGS FOR THE PUTATIVE
METABOLITES OF THALIDOMIDE TOMOYUKI SAITO 34 OP-57 FROM BENCH TO DRUG
CANDIDATE: DESIGN AND SYNTHESIS OF 5,6-FUSED-HETEROAROMATICS AS
ANTICANCER AGENTS HSING-PANG HSIEH 34 OP-58 DISCOVERY OF ANTI-CANCER
DRUG CANDIDATES ON THE BASIS OF STRUCTURAL CHEMOPROTEOMICS SEONGGU RO 35
OP-59 A NOVEL ORAL INDOLINE-SULFONAMIDE DERIVATIVE, J30, EXHIBITS POTENT
ACTIVITY AGAINST HUMAN CANCER CELLS BOTH IN VITRO AND IN VIVO THROUGH
DISRUPTION OF MICROTUBULE JANG-YANG CHANG 35 OP-60 SYNTHESIS AND
EVALUATION OF SUBSTITUTED PYRROLO[2,3-A(]PYRIMIDINES AS ANTITUMOR
ANTIMITOTICS THAT ALSO REVERSE TUMOR RESISTANCE ALEEM GANGJEE 36 OP-61
AZOLE-BRIDGED DIPLATINUM ANTICANCER DRUGS: ESCAPING REPAIR MECHANISM AND
AVOIDING CROSS-RESISTANCE BY MODULATING DNA-FLEXIBILITY ALESSANDRA
MAGISTRATO 36 OP-62 STRUCTURAL INVESTIGATION, IN VITRO ANTITUMOR PROFILE
AND AROMATASE INHIBITION EFFECTS OF NEW TRIORGANOTIN ANALOGUES OF
4-OH-ANDROSTENEDIONE (FORMESTANE) VASILIKI VALLA 37 POSTER
PRESENTATIONS (GROUP A) CHEMISTRY AND BIOLOGY FOR PHARMACEUTICALS (PA-1
TO PA-43) 38 NATURAL PRODUCTS BIOLOGICAL/PHYSIOLOGICAL ACTIVITIES (PA-44
TO PA-64) 57 BIOSYNTHETIC MEDICINAL CHEMISTRY (PA-65 TO PA-78) 66 NOVEL
DRUG TARGETS AS A BASIS OF NEW DRUG DEVELOPMENT (PA-79 TO PA-89) 72
POSTER PRESENTATIONS (GROUP B) PREDICTIVE IN SILICO METHODS AND QSAR
(PB-1 TO PB-22) 78 NEW METHODS FOR DRUG DISCOVERY (PB-23 TO PB-49) 87
RECENT APPROACHES IN ANTICANCER THERAPY (PB-50 TO PB-71) 101 ADME/TOX
(PB-72 TO PB-83) 110 POSTER PRESENTATIONS (GROUP C) MULTI-DRUG
RESISTANCE AND ITS REVERSAL (PC-1 TO PC-32) 116 OTHERS (PC-33 TO PC-73)
129 AUTHOR INDEX 147 THIS ABSTRACT BOOK HAS BEEN PRODUCED USING
ELECTRONIC SUBMISSIONS. EVERY EFFORT HAS BEEN MADE TO REPRODUCE THE
ABSTRACTS AS SUBMITTED AND AS RECEIVED BY THE PUBLISHER. A SELECTED
NUMBER OF PRESENTATIONS WILL BE AVAILABLE AS WEBCASTS. VISIT
HTTP://WWW.PROUS.COM/AIMECS07 FOR DETAILS |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author_corporate | International Medicinal Chemistry Symposium Istanbul |
| author_corporate_role | aut |
| author_facet | International Medicinal Chemistry Symposium Istanbul |
| author_sort | International Medicinal Chemistry Symposium Istanbul |
| building | Verbundindex |
| bvnumber | BV022615095 |
| ctrlnum | (OCoLC)255847893 (DE-599)BVBBV022615095 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01563nam a2200361 cb4500</leader><controlfield tag="001">BV022615095</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080121 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070820s2007 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)255847893</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV022615095</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">International Medicinal Chemistry Symposium</subfield><subfield code="n">6</subfield><subfield code="d">2007</subfield><subfield code="c">Istanbul</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)3067366-5</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Abstracts from the 6th AFMC International Medicinal Chemistry Symposium</subfield><subfield code="b">July 8 - 11, 2007, Istanbul, Turkey</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Sixth AFMC International Medicinal Chemistry Symposium</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Barcelona [u.a.]</subfield><subfield code="b">Prous</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">155 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Drugs of the future</subfield><subfield code="v">32 : Suppl.</subfield><subfield code="v">A</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-H.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2007</subfield><subfield code="z">Istanbul</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Chemie</subfield><subfield code="0">(DE-588)4132158-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Asian Federation for Medicinal Chemistry</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5262303-8</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015821252&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015821252</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2007 Istanbul gnd-content |
| genre_facet | Konferenzschrift 2007 Istanbul |
| id | DE-604.BV022615095 |
| illustrated | Illustrated |
| index_date | 2024-07-02T18:17:53Z |
| indexdate | 2024-07-09T21:01:43Z |
| institution | BVB |
| institution_GND | (DE-588)3067366-5 (DE-588)5262303-8 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015821252 |
| oclc_num | 255847893 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 155 S. Ill., graph. Darst. |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Prous |
| record_format | marc |
| series2 | Drugs of the future |
| spelling | International Medicinal Chemistry Symposium 6 2007 Istanbul Verfasser (DE-588)3067366-5 aut Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey Sixth AFMC International Medicinal Chemistry Symposium Barcelona [u.a.] Prous 2007 155 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drugs of the future 32 : Suppl. A Einzelaufnahme eines Zeitschr.-H. Pharmazeutische Chemie (DE-588)4132158-3 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2007 Istanbul gnd-content Pharmazeutische Chemie (DE-588)4132158-3 s DE-604 Asian Federation for Medicinal Chemistry Sonstige (DE-588)5262303-8 oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015821252&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey Pharmazeutische Chemie (DE-588)4132158-3 gnd |
| subject_GND | (DE-588)4132158-3 (DE-588)1071861417 |
| title | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey |
| title_alt | Sixth AFMC International Medicinal Chemistry Symposium |
| title_auth | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey |
| title_exact_search | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey |
| title_exact_search_txtP | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey |
| title_full | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey |
| title_fullStr | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey |
| title_full_unstemmed | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium July 8 - 11, 2007, Istanbul, Turkey |
| title_short | Abstracts from the 6th AFMC International Medicinal Chemistry Symposium |
| title_sort | abstracts from the 6th afmc international medicinal chemistry symposium july 8 11 2007 istanbul turkey |
| title_sub | July 8 - 11, 2007, Istanbul, Turkey |
| topic | Pharmazeutische Chemie (DE-588)4132158-3 gnd |
| topic_facet | Pharmazeutische Chemie Konferenzschrift 2007 Istanbul |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015821252&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT internationalmedicinalchemistrysymposiumistanbul abstractsfromthe6thafmcinternationalmedicinalchemistrysymposiumjuly8112007istanbulturkey AT asianfederationformedicinalchemistry abstractsfromthe6thafmcinternationalmedicinalchemistrysymposiumjuly8112007istanbulturkey AT internationalmedicinalchemistrysymposiumistanbul sixthafmcinternationalmedicinalchemistrysymposium AT asianfederationformedicinalchemistry sixthafmcinternationalmedicinalchemistrysymposium |